Purchases and Sales Made in Q4 2021 in Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM) during Q4 2021. The information is specifically focused on institutions that hold shares of Eliem Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
107K+ 53.49% |
$919K - $2.19M
|
306K
$1.26M
|
|
|
Feb 11, 2022
Q4 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
38.8K+ 50.41% |
$334K - $794K
|
116K
$475K
|
|
|
Feb 11, 2022
Q4 2021
|
Parkwood LLC
Cleveland, OH |
BUY
|
- |
30.6KNew |
$264K - $627K
|
30.6K
$126K
|
|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
24.3K+ 7.32% |
$209K - $498K
|
356K
$1.46M
|
|
|
Feb 14, 2022
Q4 2021
|
Samlyn Capital, LLC
New York, NY |
BUY
|
- |
22.5K+ 1.34% |
$194K - $461K
|
1.7M
$7M
|
|
|
Feb 15, 2022
Q4 2021
|
Chicago Partners Investment Group LLC
|
BUY
|
- |
12.5KNew |
$108K - $256K
|
12.5K
$51.3K
|
|
|
Feb 14, 2022
Q4 2021
|
Old Well Partners, LLC
Charlotte, NC |
BUY
|
- |
10.3KNew |
$88.7K - $211K
|
10.3K
$42.3K
|
|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
BUY
|
- |
6.98K+ 8.1% |
$60.1K - $143K
|
93.1K
$383K
|
|
|
Feb 14, 2022
Q4 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
6.39K+ 20622.58% |
$55K - $131K
|
6.42K
$26.4K
|
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
4.59K+ 2.26% |
$39.5K - $94K
|
208K
$855K
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
4.01K+ 65.58% |
$34.5K - $82.1K
|
10.1K
$41.6K
|
|
|
Feb 08, 2022
Q4 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
3.69K+ 600.16% |
$31.7K - $75.4K
|
4.3K
$17.7K
|
|
|
Feb 02, 2022
Q4 2021
|
New York State Common Retirement Fund
|
BUY
|
- |
3.36KNew |
$28.9K - $68.8K
|
3.36K
$13.8K
|
|
|
Jan 28, 2022
Q4 2021
|
Allspring Global Investments Holdings, LLC
|
BUY
|
- |
2.88KNew |
$24.8K - $59K
|
2.88K
$11.8K
|
|
|
Feb 10, 2022
Q4 2021
|
Citigroup Inc
|
BUY
|
- |
953+ 118.24% |
$8.21K - $19.5K
|
1.76K
$7.23K
|
|
|
Feb 11, 2022
Q4 2021
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
847+ 6.41% |
$7.29K - $17.3K
|
14.1K
$57.8K
|
|
|
Feb 14, 2022
Q4 2021
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
823+ 105.51% |
$7.09K - $16.8K
|
1.6K
$6.59K
|
|
|
Feb 14, 2022
Q4 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
510+ 103.87% |
$4.39K - $10.4K
|
1K
$4.11K
|
|
|
Feb 11, 2022
Q4 2021
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
230+ 5.66% |
$1.98K - $4.71K
|
4.29K
$17.6K
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
American International Group, Inc.
New York, NY |
SELL
|
- |
-113- 2.93% |
$973 - $2.31K
|
3.75K
$15.4K
|
|
|
Feb 08, 2022
Q4 2021
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-741- 1.19% |
$6.38K - $15.2K
|
61.3K
$252K
|
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.83K- 1.1% |
$15.7K - $37.4K
|
164K
$675K
|
|
|
Feb 07, 2022
Q4 2021
|
Monashee Investment Management LLC
Boston, MA |
SELL
|
- |
-5.23K- 1.71% |
$45.1K - $107K
|
300K
$1.23M
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
SELL
|
- |
-9.44K- 68.01% |
$81.2K - $193K
|
4.44K
$18.2K
|
|
|
Feb 14, 2022
Q4 2021
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-11.8KClosed |
$102K - $241K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-13.9K- 3.58% |
$119K - $284K
|
373K
$1.53M
|
|
|
Feb 14, 2022
Q4 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-14.9KClosed |
$128K - $305K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
SELL
|
- |
-91.8K- 31.97% |
$791K - $1.88M
|
195K
$803K
|